Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
June 3, 2019 Off

PharmaCyte Biotech CEO Visiting GMP Facility with Cellular Biology Consultant During Production of Pancreatic Cancer Product

By BusinessWire

LAGUNA HILLS, Calif.–(BUSINESS WIRE)–#INDstatus—PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted cellular therapies for…

June 3, 2019 Off

Takeda Presents Results from Lung Portfolio Including Phase 1/2 Study of TAK-788 in a Rare Form of NSCLC and New Data on Overall Health-Related Quality of Life for ALUNBRIG® (brigatinib)

By BusinessWire

– Phase 1/2 Data Being Presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting Demonstrated TAK-788 Extended…

June 3, 2019 Off

June is Cancer Survivors Month: AscellaHealth Helps Improve Outcomes, Lower Costs with High-Touch Specialty Pharmacy Solutions

By BusinessWire

Advocating on behalf of cancer survivors on June 4, 2019, National Cancer Survivors Day BERWYN, Pa.–(BUSINESS WIRE)–AscellaHealth a specialty-focused pharmaceutical…

June 3, 2019 Off

Atomwise Announces Multi-year, Multi-target Agreement with Lilly for AI-Driven Drug Discovery Program

By BusinessWire

SAN FRANCISCO–(BUSINESS WIRE)–Atomwise Inc. today announced a multi-year agreement with Eli Lilly and Company to apply Atomwise’s patented artificial intelligence…

June 3, 2019 Off

Clinical Benefit and Safety of LONSURF® (trifluridine/tipiracil) Reinforced by New Data Presented at the 2019 ASCO Annual Meeting

By BusinessWire

PARIS–(BUSINESS WIRE)–Servier and Taiho Oncology, Inc. a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), today presented LONSURF® (trifluridine/tipiracil, TAS-102) clinical…

June 3, 2019 Off

Parexel Appoints Dr. Makoto Sugita to Lead its Japan Organization

By BusinessWire

Industry Veteran Brings Specialized Expertise in Medical Affairs, Medical Device and Real-World Evidence to Key Leadership Role in Fast-Growing Region…

June 3, 2019 Off

CEL-SCI Corporation to Present at the 9th Annual LD Micro Invitational

By BusinessWire

VIENNA, Va.–(BUSINESS WIRE)–CEL-SCI Corporation (NYSE American: CVM), a Phase 3 cancer immunotherapy company, today announced that it will be presenting…

June 3, 2019 Off

Qurient Announces Positive Phase 2a Data of Novel Antibiotic for the Treatment of Tuberculosis

By BusinessWire

SEONGNAM-SI, South Korea–(BUSINESS WIRE)–Qurient Co. Ltd. today announced positive results from the Phase 2a EBA (early bactericidal activity) clinical trial…

June 3, 2019 Off

Independent Data Monitoring Committee (IDMC) Recommends CONTESSA Continue with No Modifications following Planned Interim Efficacy Futility Analysis

By BusinessWire

SAN DIEGO–(BUSINESS WIRE)–Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and…

June 3, 2019 Off

GeneCentric Therapeutics Presents First Data on Novel Response Signatures to Treatment in Muscle Invasive Bladder Cancer (MIBC) Patients

By BusinessWire

Data presented at 2019 ASCO Annual Meeting DURHAM, N.C.–(BUSINESS WIRE)–GeneCentric Therapeutics will present the first data on novel response signatures…

Posts pagination

Previous 1 … 3,138 3,139 3,140 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine